Cancer is a word that is becoming more frequent in our society. It is hard to find someone that has not been affected by cancer in some way. The fight against cancer has been going on for decades. The treatment for the disease has advanced greatly, but a cure has yet to be discovered. Eric Lefkofsky and his company, Tempus, are doing everything they can to help in this fight.
Eric Lefkofksy has been a businessman his entire adult life. He and his business partner have been involved in and created many companies. One of the greatest company successes that Eric Lefkofksy has been involved with is Groupon. He was an original investor and creator for the company. This company has expanded greatly and is still wildly popular. This company even earned the title of the fastest growing company in history. Check lefkofsky.com for more details.
Based in tempus.com, in 2016, Eric created his current company called Tempus. Tempus is a technology company, and they have created a machine that helps doctors treating cancer patients. The machine analyzes data and gives doctors a closer look into what exactly is going on inside the bodies of their patients.
Blood and tissue samples are taken from the patients. These samples are sent off to the Tempus lab. An analysis of the DNA and RNA sequencing is done on the samples. Cancer cells and normal cells are compared to see if there are any mutations in the gene makeup. The results are then sent back to the doctors. This process takes roughly three weeks.
Once the doctors receive the results, they have a clearer picture of what is happening with their patients. Each patient is different and having these results allows for their treatment plan to be customized. The more information doctors have, the better they are able to treat their patients.
Eric Lefkofsky’s company may be new, but it is having a great impact. Cancer treatment centers all over the country are using their services. The battle against cancer has not yet been won, but with the machine created by Tempus, we may be getting closer to that goal.